Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-31T14:50:58.385Z Has data issue: false hasContentIssue false
  • English
  • Français

A Single Daily Dose of a New Form of Amitriptyline in Depressive Illness

Published online by Cambridge University Press:  29 January 2018

Ijaz Haider
Ijaz Haider*
Affiliation:
Department of Psychological Medicine, Welsh National School of Medicine, Cardiff; now Consultant Psychiatrist (specialist in Mental Diseases) Government Mental Hospital, Lahore, West Pakistan
Get access Rights & Permissions [Opens in a new window]

Extract

In order to try to overcome the common clinical experience of patients who do not take the drugs prescribed for them (Wilcox et al., 1965) a sustained release form of amitriptyline (Lentizol) has recently been made available. This trial was undertaken to test the efficacy of this formulation given once daily at night compared to standard amitriptyline given thrice daily.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 120 , Issue 558 , May 1972 , pp. 521 - 522
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Medical Research Council (1965). ‘Clinical trial of the treatment of depressive illness.’ Report by the Clinical Psychiatry Committee. British Medical Journal, i, 881–6.Google Scholar
Wilcox, D. R. C., Gillen, R., and Hare, E. H. (1965). ‘Do psychiatric out-patients take their drugs?’ British Medical Journal, ii, 790–2.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.